カテゴリー： LP Information, 世界, 部品/材料

世界のイデラリシブ市場予測 2023年-2029年

◆英語タイトル：Global Idelalisib (CAL-101) Market Growth 2023-2029
	◆商品コード：LP23JU2014 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：118 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のイデラリシブ市場」は、過去の販売実績から2022年の世界のイデラリシブの総販売量を検討し、2023年から2029年の予測されるイデラリシブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のイデラリシブの市場規模を掲載し、XXX百万米ドル規模の世界のイデラリシブ市場の詳細な分析を提供します。本インサイトレポートは、世界のイデラリシブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のイデラリシブ市場における各社の独自のポジションをより深く理解するために、イデラリシブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のイデラリシブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。イデラリシブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。イデラリシブの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。イデラリシブのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

イデラリシブの世界主要メーカーとしては、TCI、 Biosynth Carbosynth、 BOC Sciences、 Focus Biomolecules、 Adooq Bioscience、 Selleck Chemicals、 Enzo Biochem、 Axon Medchem、 BioVision、 Santa Cruz Biotechnology、 Clearsynth、 LGC、 LKT Laboratories、 Shimadzu、 Aladdin、 Cayman Chemicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のイデラリシブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではイデラリシブ市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のイデラリシブ市場の10年間の市場状況・展望は？
・世界および地域別に見たイデラリシブ市場成長の要因は何か？
・イデラリシブの市場機会はエンドマーケットの規模によってどのように変化するのか？
・イデラリシブのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：イデラリシブの年間販売量2018-2029、地域別現状・将来分析
・イデラリシブの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・イデラリシブの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・イデラリシブの用途別セグメント：研究、医療
・イデラリシブの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のイデラリシブ市場
・企業別のグローバルイデラリシブ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のイデラリシブの年間売上：2018-2023年の売上、市場シェア
・企業別のイデラリシブ販売価格
・主要企業のイデラリシブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

イデラリシブの地域別レビュー
・地域別のイデラリシブ市場規模2018-2023：年間販売量、売上
・主要国別のイデラリシブ市場規模2018-2023：年間販売量、売上
・南北アメリカのイデラリシブ販売の成長
・アジア太平洋のイデラリシブ販売の成長
・ヨーロッパのイデラリシブ販売の成長
・中東・アフリカのイデラリシブ販売の成長

南北アメリカ市場
・南北アメリカの国別のイデラリシブ販売量、売上（2018-2023）
・南北アメリカのイデラリシブの種類別販売量
・南北アメリカのイデラリシブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のイデラリシブ販売量、売上（2018-2023）
・アジア太平洋のイデラリシブの種類別販売量
・アジア太平洋のイデラリシブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のイデラリシブ販売量、売上（2018-2023）
・ヨーロッパのイデラリシブの種類別販売量
・ヨーロッパのイデラリシブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のイデラリシブ販売量、売上（2018-2023）
・中東・アフリカのイデラリシブの種類別販売量
・中東・アフリカのイデラリシブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・イデラリシブの製造コスト構造分析
・イデラリシブの製造プロセス分析
・イデラリシブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・イデラリシブの主要なグローバル販売業者
・イデラリシブの主要なグローバル顧客

地域別のイデラリシブ市場予測レビュー
・地域別のイデラリシブ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・イデラリシブの種類別市場規模予測
・イデラリシブの用途別市場規模予測

主要企業分析
TCI、 Biosynth Carbosynth、 BOC Sciences、 Focus Biomolecules、 Adooq Bioscience、 Selleck Chemicals、 Enzo Biochem、 Axon Medchem、 BioVision、 Santa Cruz Biotechnology、 Clearsynth、 LGC、 LKT Laboratories、 Shimadzu、 Aladdin、 Cayman Chemical
・企業情報
・イデラリシブ製品
・イデラリシブ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
LPI (LP Information)’ newest research report, the “Idelalisib (CAL-101) Industry Forecast” looks at past sales and reviews total world Idelalisib (CAL-101) sales in 2022, providing a comprehensive analysis by region and market sector of projected Idelalisib (CAL-101) sales for 2023 through 2029. With Idelalisib (CAL-101) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Idelalisib (CAL-101) industry.
This Insight Report provides a comprehensive analysis of the global Idelalisib (CAL-101) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Idelalisib (CAL-101) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Idelalisib (CAL-101) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Idelalisib (CAL-101) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Idelalisib (CAL-101).
The global Idelalisib (CAL-101) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Idelalisib (CAL-101) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Idelalisib (CAL-101) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Idelalisib (CAL-101) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Idelalisib (CAL-101) players cover TCI, Biosynth Carbosynth, BOC Sciences, Focus Biomolecules, Adooq Bioscience, Selleck Chemicals, Enzo Biochem, Axon Medchem and BioVision, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Idelalisib (CAL-101) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Idelalisib (CAL-101) market?
What factors are driving Idelalisib (CAL-101) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Idelalisib (CAL-101) market opportunities vary by end market size?
How does Idelalisib (CAL-101) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Idelalisib (CAL-101) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Idelalisib (CAL-101) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Idelalisib (CAL-101) by Country/Region, 2018, 2022 & 2029
2.2 Idelalisib (CAL-101) Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Idelalisib (CAL-101) Sales by Type
2.3.1 Global Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
2.3.2 Global Idelalisib (CAL-101) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Idelalisib (CAL-101) Sale Price by Type (2018-2023)
2.4 Idelalisib (CAL-101) Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Idelalisib (CAL-101) Sales by Application
2.5.1 Global Idelalisib (CAL-101) Sale Market Share by Application (2018-2023)
2.5.2 Global Idelalisib (CAL-101) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Idelalisib (CAL-101) Sale Price by Application (2018-2023)
3 Global Idelalisib (CAL-101) by Company
3.1 Global Idelalisib (CAL-101) Breakdown Data by Company
3.1.1 Global Idelalisib (CAL-101) Annual Sales by Company (2018-2023)
3.1.2 Global Idelalisib (CAL-101) Sales Market Share by Company (2018-2023)
3.2 Global Idelalisib (CAL-101) Annual Revenue by Company (2018-2023)
3.2.1 Global Idelalisib (CAL-101) Revenue by Company (2018-2023)
3.2.2 Global Idelalisib (CAL-101) Revenue Market Share by Company (2018-2023)
3.3 Global Idelalisib (CAL-101) Sale Price by Company
3.4 Key Manufacturers Idelalisib (CAL-101) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Idelalisib (CAL-101) Product Location Distribution
3.4.2 Players Idelalisib (CAL-101) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Idelalisib (CAL-101) by Geographic Region
4.1 World Historic Idelalisib (CAL-101) Market Size by Geographic Region (2018-2023)
4.1.1 Global Idelalisib (CAL-101) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Idelalisib (CAL-101) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Idelalisib (CAL-101) Market Size by Country/Region (2018-2023)
4.2.1 Global Idelalisib (CAL-101) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Idelalisib (CAL-101) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Idelalisib (CAL-101) Sales Growth
4.4 APAC Idelalisib (CAL-101) Sales Growth
4.5 Europe Idelalisib (CAL-101) Sales Growth
4.6 Middle East & Africa Idelalisib (CAL-101) Sales Growth
5 Americas
5.1 Americas Idelalisib (CAL-101) Sales by Country
5.1.1 Americas Idelalisib (CAL-101) Sales by Country (2018-2023)
5.1.2 Americas Idelalisib (CAL-101) Revenue by Country (2018-2023)
5.2 Americas Idelalisib (CAL-101) Sales by Type
5.3 Americas Idelalisib (CAL-101) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Idelalisib (CAL-101) Sales by Region
6.1.1 APAC Idelalisib (CAL-101) Sales by Region (2018-2023)
6.1.2 APAC Idelalisib (CAL-101) Revenue by Region (2018-2023)
6.2 APAC Idelalisib (CAL-101) Sales by Type
6.3 APAC Idelalisib (CAL-101) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Idelalisib (CAL-101) by Country
7.1.1 Europe Idelalisib (CAL-101) Sales by Country (2018-2023)
7.1.2 Europe Idelalisib (CAL-101) Revenue by Country (2018-2023)
7.2 Europe Idelalisib (CAL-101) Sales by Type
7.3 Europe Idelalisib (CAL-101) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Idelalisib (CAL-101) by Country
8.1.1 Middle East & Africa Idelalisib (CAL-101) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Idelalisib (CAL-101) Revenue by Country (2018-2023)
8.2 Middle East & Africa Idelalisib (CAL-101) Sales by Type
8.3 Middle East & Africa Idelalisib (CAL-101) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Idelalisib (CAL-101)
10.3 Manufacturing Process Analysis of Idelalisib (CAL-101)
10.4 Industry Chain Structure of Idelalisib (CAL-101)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Idelalisib (CAL-101) Distributors
11.3 Idelalisib (CAL-101) Customer
12 World Forecast Review for Idelalisib (CAL-101) by Geographic Region
12.1 Global Idelalisib (CAL-101) Market Size Forecast by Region
12.1.1 Global Idelalisib (CAL-101) Forecast by Region (2024-2029)
12.1.2 Global Idelalisib (CAL-101) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Idelalisib (CAL-101) Forecast by Type
12.7 Global Idelalisib (CAL-101) Forecast by Application
13 Key Players Analysis
13.1 TCI
13.1.1 TCI Company Information
13.1.2 TCI Idelalisib (CAL-101) Product Portfolios and Specifications
13.1.3 TCI Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 TCI Main Business Overview
13.1.5 TCI Latest Developments
13.2 Biosynth Carbosynth
13.2.1 Biosynth Carbosynth Company Information
13.2.2 Biosynth Carbosynth Idelalisib (CAL-101) Product Portfolios and Specifications
13.2.3 Biosynth Carbosynth Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biosynth Carbosynth Main Business Overview
13.2.5 Biosynth Carbosynth Latest Developments
13.3 BOC Sciences
13.3.1 BOC Sciences Company Information
13.3.2 BOC Sciences Idelalisib (CAL-101) Product Portfolios and Specifications
13.3.3 BOC Sciences Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BOC Sciences Main Business Overview
13.3.5 BOC Sciences Latest Developments
13.4 Focus Biomolecules
13.4.1 Focus Biomolecules Company Information
13.4.2 Focus Biomolecules Idelalisib (CAL-101) Product Portfolios and Specifications
13.4.3 Focus Biomolecules Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Focus Biomolecules Main Business Overview
13.4.5 Focus Biomolecules Latest Developments
13.5 Adooq Bioscience
13.5.1 Adooq Bioscience Company Information
13.5.2 Adooq Bioscience Idelalisib (CAL-101) Product Portfolios and Specifications
13.5.3 Adooq Bioscience Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Adooq Bioscience Main Business Overview
13.5.5 Adooq Bioscience Latest Developments
13.6 Selleck Chemicals
13.6.1 Selleck Chemicals Company Information
13.6.2 Selleck Chemicals Idelalisib (CAL-101) Product Portfolios and Specifications
13.6.3 Selleck Chemicals Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Selleck Chemicals Main Business Overview
13.6.5 Selleck Chemicals Latest Developments
13.7 Enzo Biochem
13.7.1 Enzo Biochem Company Information
13.7.2 Enzo Biochem Idelalisib (CAL-101) Product Portfolios and Specifications
13.7.3 Enzo Biochem Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Enzo Biochem Main Business Overview
13.7.5 Enzo Biochem Latest Developments
13.8 Axon Medchem
13.8.1 Axon Medchem Company Information
13.8.2 Axon Medchem Idelalisib (CAL-101) Product Portfolios and Specifications
13.8.3 Axon Medchem Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Axon Medchem Main Business Overview
13.8.5 Axon Medchem Latest Developments
13.9 BioVision
13.9.1 BioVision Company Information
13.9.2 BioVision Idelalisib (CAL-101) Product Portfolios and Specifications
13.9.3 BioVision Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BioVision Main Business Overview
13.9.5 BioVision Latest Developments
13.10 Santa Cruz Biotechnology
13.10.1 Santa Cruz Biotechnology Company Information
13.10.2 Santa Cruz Biotechnology Idelalisib (CAL-101) Product Portfolios and Specifications
13.10.3 Santa Cruz Biotechnology Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Santa Cruz Biotechnology Main Business Overview
13.10.5 Santa Cruz Biotechnology Latest Developments
13.11 Clearsynth
13.11.1 Clearsynth Company Information
13.11.2 Clearsynth Idelalisib (CAL-101) Product Portfolios and Specifications
13.11.3 Clearsynth Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Clearsynth Main Business Overview
13.11.5 Clearsynth Latest Developments
13.12 LGC
13.12.1 LGC Company Information
13.12.2 LGC Idelalisib (CAL-101) Product Portfolios and Specifications
13.12.3 LGC Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 LGC Main Business Overview
13.12.5 LGC Latest Developments
13.13 LKT Laboratories
13.13.1 LKT Laboratories Company Information
13.13.2 LKT Laboratories Idelalisib (CAL-101) Product Portfolios and Specifications
13.13.3 LKT Laboratories Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 LKT Laboratories Main Business Overview
13.13.5 LKT Laboratories Latest Developments
13.14 Shimadzu
13.14.1 Shimadzu Company Information
13.14.2 Shimadzu Idelalisib (CAL-101) Product Portfolios and Specifications
13.14.3 Shimadzu Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shimadzu Main Business Overview
13.14.5 Shimadzu Latest Developments
13.15 Aladdin
13.15.1 Aladdin Company Information
13.15.2 Aladdin Idelalisib (CAL-101) Product Portfolios and Specifications
13.15.3 Aladdin Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Aladdin Main Business Overview
13.15.5 Aladdin Latest Developments
13.16 Cayman Chemical
13.16.1 Cayman Chemical Company Information
13.16.2 Cayman Chemical Idelalisib (CAL-101) Product Portfolios and Specifications
13.16.3 Cayman Chemical Idelalisib (CAL-101) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cayman Chemical Main Business Overview
13.16.5 Cayman Chemical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Idelalisib (CAL-101) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Idelalisib (CAL-101) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Idelalisib (CAL-101) Sales by Type (2018-2023) & (Kg)
Table 7. Global Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
Table 8. Global Idelalisib (CAL-101) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Idelalisib (CAL-101) Revenue Market Share by Type (2018-2023)
Table 10. Global Idelalisib (CAL-101) Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Idelalisib (CAL-101) Sales by Application (2018-2023) & (Kg)
Table 12. Global Idelalisib (CAL-101) Sales Market Share by Application (2018-2023)
Table 13. Global Idelalisib (CAL-101) Revenue by Application (2018-2023)
Table 14. Global Idelalisib (CAL-101) Revenue Market Share by Application (2018-2023)
Table 15. Global Idelalisib (CAL-101) Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Idelalisib (CAL-101) Sales by Company (2018-2023) & (Kg)
Table 17. Global Idelalisib (CAL-101) Sales Market Share by Company (2018-2023)
Table 18. Global Idelalisib (CAL-101) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Idelalisib (CAL-101) Revenue Market Share by Company (2018-2023)
Table 20. Global Idelalisib (CAL-101) Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Idelalisib (CAL-101) Producing Area Distribution and Sales Area
Table 22. Players Idelalisib (CAL-101) Products Offered
Table 23. Idelalisib (CAL-101) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Idelalisib (CAL-101) Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Idelalisib (CAL-101) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Idelalisib (CAL-101) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Idelalisib (CAL-101) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Idelalisib (CAL-101) Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Idelalisib (CAL-101) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Idelalisib (CAL-101) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Idelalisib (CAL-101) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Idelalisib (CAL-101) Sales by Country (2018-2023) & (Kg)
Table 35. Americas Idelalisib (CAL-101) Sales Market Share by Country (2018-2023)
Table 36. Americas Idelalisib (CAL-101) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Idelalisib (CAL-101) Revenue Market Share by Country (2018-2023)
Table 38. Americas Idelalisib (CAL-101) Sales by Type (2018-2023) & (Kg)
Table 39. Americas Idelalisib (CAL-101) Sales by Application (2018-2023) & (Kg)
Table 40. APAC Idelalisib (CAL-101) Sales by Region (2018-2023) & (Kg)
Table 41. APAC Idelalisib (CAL-101) Sales Market Share by Region (2018-2023)
Table 42. APAC Idelalisib (CAL-101) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Idelalisib (CAL-101) Revenue Market Share by Region (2018-2023)
Table 44. APAC Idelalisib (CAL-101) Sales by Type (2018-2023) & (Kg)
Table 45. APAC Idelalisib (CAL-101) Sales by Application (2018-2023) & (Kg)
Table 46. Europe Idelalisib (CAL-101) Sales by Country (2018-2023) & (Kg)
Table 47. Europe Idelalisib (CAL-101) Sales Market Share by Country (2018-2023)
Table 48. Europe Idelalisib (CAL-101) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Idelalisib (CAL-101) Revenue Market Share by Country (2018-2023)
Table 50. Europe Idelalisib (CAL-101) Sales by Type (2018-2023) & (Kg)
Table 51. Europe Idelalisib (CAL-101) Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Idelalisib (CAL-101) Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Idelalisib (CAL-101) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Idelalisib (CAL-101) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Idelalisib (CAL-101) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Idelalisib (CAL-101) Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Idelalisib (CAL-101) Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Idelalisib (CAL-101)
Table 59. Key Market Challenges & Risks of Idelalisib (CAL-101)
Table 60. Key Industry Trends of Idelalisib (CAL-101)
Table 61. Idelalisib (CAL-101) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Idelalisib (CAL-101) Distributors List
Table 64. Idelalisib (CAL-101) Customer List
Table 65. Global Idelalisib (CAL-101) Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Idelalisib (CAL-101) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Idelalisib (CAL-101) Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Idelalisib (CAL-101) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Idelalisib (CAL-101) Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Idelalisib (CAL-101) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Idelalisib (CAL-101) Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Idelalisib (CAL-101) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Idelalisib (CAL-101) Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Idelalisib (CAL-101) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Idelalisib (CAL-101) Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Idelalisib (CAL-101) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Idelalisib (CAL-101) Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Idelalisib (CAL-101) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. TCI Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 80. TCI Idelalisib (CAL-101) Product Portfolios and Specifications
Table 81. TCI Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. TCI Main Business
Table 83. TCI Latest Developments
Table 84. Biosynth Carbosynth Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 85. Biosynth Carbosynth Idelalisib (CAL-101) Product Portfolios and Specifications
Table 86. Biosynth Carbosynth Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Biosynth Carbosynth Main Business
Table 88. Biosynth Carbosynth Latest Developments
Table 89. BOC Sciences Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 90. BOC Sciences Idelalisib (CAL-101) Product Portfolios and Specifications
Table 91. BOC Sciences Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. BOC Sciences Main Business
Table 93. BOC Sciences Latest Developments
Table 94. Focus Biomolecules Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 95. Focus Biomolecules Idelalisib (CAL-101) Product Portfolios and Specifications
Table 96. Focus Biomolecules Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Focus Biomolecules Main Business
Table 98. Focus Biomolecules Latest Developments
Table 99. Adooq Bioscience Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 100. Adooq Bioscience Idelalisib (CAL-101) Product Portfolios and Specifications
Table 101. Adooq Bioscience Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. Adooq Bioscience Main Business
Table 103. Adooq Bioscience Latest Developments
Table 104. Selleck Chemicals Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 105. Selleck Chemicals Idelalisib (CAL-101) Product Portfolios and Specifications
Table 106. Selleck Chemicals Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Selleck Chemicals Main Business
Table 108. Selleck Chemicals Latest Developments
Table 109. Enzo Biochem Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 110. Enzo Biochem Idelalisib (CAL-101) Product Portfolios and Specifications
Table 111. Enzo Biochem Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. Enzo Biochem Main Business
Table 113. Enzo Biochem Latest Developments
Table 114. Axon Medchem Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 115. Axon Medchem Idelalisib (CAL-101) Product Portfolios and Specifications
Table 116. Axon Medchem Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. Axon Medchem Main Business
Table 118. Axon Medchem Latest Developments
Table 119. BioVision Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 120. BioVision Idelalisib (CAL-101) Product Portfolios and Specifications
Table 121. BioVision Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. BioVision Main Business
Table 123. BioVision Latest Developments
Table 124. Santa Cruz Biotechnology Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 125. Santa Cruz Biotechnology Idelalisib (CAL-101) Product Portfolios and Specifications
Table 126. Santa Cruz Biotechnology Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Santa Cruz Biotechnology Main Business
Table 128. Santa Cruz Biotechnology Latest Developments
Table 129. Clearsynth Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 130. Clearsynth Idelalisib (CAL-101) Product Portfolios and Specifications
Table 131. Clearsynth Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. Clearsynth Main Business
Table 133. Clearsynth Latest Developments
Table 134. LGC Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 135. LGC Idelalisib (CAL-101) Product Portfolios and Specifications
Table 136. LGC Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 137. LGC Main Business
Table 138. LGC Latest Developments
Table 139. LKT Laboratories Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 140. LKT Laboratories Idelalisib (CAL-101) Product Portfolios and Specifications
Table 141. LKT Laboratories Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 142. LKT Laboratories Main Business
Table 143. LKT Laboratories Latest Developments
Table 144. Shimadzu Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 145. Shimadzu Idelalisib (CAL-101) Product Portfolios and Specifications
Table 146. Shimadzu Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 147. Shimadzu Main Business
Table 148. Shimadzu Latest Developments
Table 149. Aladdin Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 150. Aladdin Idelalisib (CAL-101) Product Portfolios and Specifications
Table 151. Aladdin Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 152. Aladdin Main Business
Table 153. Aladdin Latest Developments
Table 154. Cayman Chemical Basic Information, Idelalisib (CAL-101) Manufacturing Base, Sales Area and Its Competitors
Table 155. Cayman Chemical Idelalisib (CAL-101) Product Portfolios and Specifications
Table 156. Cayman Chemical Idelalisib (CAL-101) Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 157. Cayman Chemical Main Business
Table 158. Cayman Chemical Latest Developments
List of Figures
Figure 1. Picture of Idelalisib (CAL-101)
Figure 2. Idelalisib (CAL-101) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Idelalisib (CAL-101) Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Idelalisib (CAL-101) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Idelalisib (CAL-101) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Idelalisib (CAL-101) Sales Market Share by Type in 2022
Figure 13. Global Idelalisib (CAL-101) Revenue Market Share by Type (2018-2023)
Figure 14. Idelalisib (CAL-101) Consumed in Research
Figure 15. Global Idelalisib (CAL-101) Market: Research (2018-2023) & (Kg)
Figure 16. Idelalisib (CAL-101) Consumed in Medical
Figure 17. Global Idelalisib (CAL-101) Market: Medical (2018-2023) & (Kg)
Figure 18. Global Idelalisib (CAL-101) Sales Market Share by Application (2022)
Figure 19. Global Idelalisib (CAL-101) Revenue Market Share by Application in 2022
Figure 20. Idelalisib (CAL-101) Sales Market by Company in 2022 (Kg)
Figure 21. Global Idelalisib (CAL-101) Sales Market Share by Company in 2022
Figure 22. Idelalisib (CAL-101) Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Idelalisib (CAL-101) Revenue Market Share by Company in 2022
Figure 24. Global Idelalisib (CAL-101) Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Idelalisib (CAL-101) Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Idelalisib (CAL-101) Sales 2018-2023 (Kg)
Figure 27. Americas Idelalisib (CAL-101) Revenue 2018-2023 ($ Millions)
Figure 28. APAC Idelalisib (CAL-101) Sales 2018-2023 (Kg)
Figure 29. APAC Idelalisib (CAL-101) Revenue 2018-2023 ($ Millions)
Figure 30. Europe Idelalisib (CAL-101) Sales 2018-2023 (Kg)
Figure 31. Europe Idelalisib (CAL-101) Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Idelalisib (CAL-101) Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Idelalisib (CAL-101) Revenue 2018-2023 ($ Millions)
Figure 34. Americas Idelalisib (CAL-101) Sales Market Share by Country in 2022
Figure 35. Americas Idelalisib (CAL-101) Revenue Market Share by Country in 2022
Figure 36. Americas Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
Figure 37. Americas Idelalisib (CAL-101) Sales Market Share by Application (2018-2023)
Figure 38. United States Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Idelalisib (CAL-101) Sales Market Share by Region in 2022
Figure 43. APAC Idelalisib (CAL-101) Revenue Market Share by Regions in 2022
Figure 44. APAC Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
Figure 45. APAC Idelalisib (CAL-101) Sales Market Share by Application (2018-2023)
Figure 46. China Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Idelalisib (CAL-101) Sales Market Share by Country in 2022
Figure 54. Europe Idelalisib (CAL-101) Revenue Market Share by Country in 2022
Figure 55. Europe Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
Figure 56. Europe Idelalisib (CAL-101) Sales Market Share by Application (2018-2023)
Figure 57. Germany Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Idelalisib (CAL-101) Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Idelalisib (CAL-101) Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Idelalisib (CAL-101) Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Idelalisib (CAL-101) Sales Market Share by Application (2018-2023)
Figure 66. Egypt Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Idelalisib (CAL-101) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Idelalisib (CAL-101) in 2022
Figure 72. Manufacturing Process Analysis of Idelalisib (CAL-101)
Figure 73. Industry Chain Structure of Idelalisib (CAL-101)
Figure 74. Channels of Distribution
Figure 75. Global Idelalisib (CAL-101) Sales Market Forecast by Region (2024-2029)
Figure 76. Global Idelalisib (CAL-101) Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Idelalisib (CAL-101) Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Idelalisib (CAL-101) Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Idelalisib (CAL-101) Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Idelalisib (CAL-101) Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のイデラリシブ市場予測 2023年-2029年(Global Idelalisib (CAL-101) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のイデラリシブ市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp